Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
TransCode Therapeutics Inc. (NASDAQ: RNAZ)
Investment Considerations Lead candidate TTX-MC138 is advancing through a Phase I/II clinical trial for metastatic cancers, targeting the critical miR-10b biomarker. Proprietary TTX platform addresses a long-standing delivery bottleneck in RNA-based oncology drug development. Strategic collaborations with institutions like Massachusetts General Hospital and MD Anderson Cancer Center validate scientific rigor. Early human data demonstrates effective … Continue reading “TransCode Therapeutics Inc. (NASDAQ: RNAZ)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
